Lv4
556 积分 2025-03-26 加入
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
26天前
已完结
Sacituzumab Tirumotecan plus Pembrolizumab in PD-L1–Negative Advanced NSCLC
26天前
已完结
Oral mucositis associated with antibody-drug conjugates in gynecologic oncology: strategies for prevention and treatment
2个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
3个月前
已完结
Sample size slippages in randomised trials: exclusions and the lost and wayward
3个月前
已完结
Cytologic detection of malignancy in pleural effusion: A review of 5,255 samples from 3,811 patients
3个月前
已完结
Prediction of overall survival through circadian rest‐activity monitoring during chemotherapy for metastatic colorectal cancer
3个月前
已完结
Definition and classification of cancer cachexia: an international consensus
3个月前
已完结
Endostar combined with irinotecan/calcium folinate/5-fluorouracil (FOLFIRI) for treating advanced colorectal cancer: A clinical study
3个月前
已完结